Skip to main content
IVVD
NASDAQ Life Sciences

Invivyd's VYD2311 Shows Superior Safety vs mRNA Vaccine, BLA Filing Planned

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$1.16
Mkt Cap
$280.021M
52W Low
$0.528
52W High
$3.07
52W Position info
120% above low
Off High info
62% below high
Rel. Volume info
2.6× avg
Market data snapshot near publication time

IVVD has more than doubled off its 52-week low of $0.528 on elevated volume (2.6× avg).

Summary

Invivyd announced positive topline results from its Liberty Phase 3 study, showing VYD2311 has superior safety and tolerability compared to mRNA-based COVID-19 vaccines. The company also plans to submit a Biologics License Application (BLA) to the FDA via the accelerated approval pathway. This is a major development for a company facing going concern doubts, a Nasdaq delisting notice, and the loss of its only authorized product's EUA. The positive data and regulatory path forward could significantly change the company's outlook. Investors should watch for the actual BLA submission and any FDA feedback.

At the time of this announcement, IVVD was trading at $1.16 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $280M. The 52-week trading range was $0.53 to $3.07. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

IVVD - Latest Insights

IVVD
Nov 16, 2026, 7:10 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.5867
Real-time Price: $0.4501 info
Change: -$0.1366 (-23%) info
Market Cap: $137.025M info
IVVD
Nov 16, 2026, 7:08 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.562
Real-time Price: $0.4501 info
Change: -$0.1119 (-20%) info
Market Cap: $137.025M info
IVVD
Nov 16, 2026, 7:02 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $0.5731
Real-time Price: $0.4501 info
Change: -$0.123 (-21%) info
Market Cap: $137.025M info
IVVD
Sep 29, 2026, 7:26 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.9635
Real-time Price: $0.4501 info
Change: -$0.5134 (-53%) info
Market Cap: $137.025M info
IVVD
Sep 01, 2026, 7:10 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.9303
Real-time Price: $0.4501 info
Change: -$0.4802 (-52%) info
Market Cap: $137.025M info